Shane Barton - Sep 27, 2024 Form 4 Insider Report for BioAge Labs, Inc. (BIOA)

Role
Principal Accounting Officer
Signature
/s/ Dov A. Goldstein as attorney-in-fact
Stock symbol
BIOA
Transactions as of
Sep 27, 2024
Transactions value $
$47,376
Form type
4
Date filed
3/10/2025, 04:10 PM
Previous filing
Sep 25, 2024
Next filing
Dec 20, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIOA Common Stock Purchase $47.4K +2.63K $18.00 2.63K Sep 27, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities were purchased through a directed share program in connection with the Issuer's initial public offering.